Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Garraffo

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Therapie|September 1, 1992
[Thrombopenia due to pefloxacin (Peflacine): dose-dependent toxicity?]R M Chichmanian, A Spreux, E Bernard, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Comparison of the pharmacokinetics of theophylline administered i.v. per os with continuous enteral feeding]M Raucoules, P Benoit, C Ichai, et al.
Pathologie-Biologie|May 1, 1984
[Bone levels of dibekacin]P Dellamonica, H Etesse, R Garraffo, et al.
The American Journal of Cardiology|September 15, 1989
Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmiasM D Drici, V Sbirrazzuoli, R Garraffo, et al.
Presse Medicale (Paris, France : 1983)|December 23, 2004
[The use of fluoroquinolone plasma levels by physicians]C Pulcini, E Bernard, R Garraffo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1989
Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reportsR Garraffo, E Cassuto-Viguier, J Barillon, et al.
Lancet (London, England)|July 29, 1989
Fetoplacental passage of zidovudineJ Y Gillet, R Garraffo, D Abrar, et al.
Investigative Ophthalmology & Visual Science|March 1, 1994
Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovirP Berthe, C Baudouin, R Garraffo, et al.
Pathologie-Biologie|April 1, 1991
[Determination of elimination of pefloxacin and of its derivatives in continuous hemodiafiltration]D Journois, D Chanu, J M Ruat, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatmentV Sbirrazzuoli, M Drici, R Garraffo, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Therapie|September 1, 1992
[Thrombopenia due to pefloxacin (Peflacine): dose-dependent toxicity?]R M Chichmanian, A Spreux, E Bernard, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Comparison of the pharmacokinetics of theophylline administered i.v. per os with continuous enteral feeding]M Raucoules, P Benoit, C Ichai, et al.
Pathologie-Biologie|May 1, 1984
[Bone levels of dibekacin]P Dellamonica, H Etesse, R Garraffo, et al.
The American Journal of Cardiology|September 15, 1989
Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmiasM D Drici, V Sbirrazzuoli, R Garraffo, et al.
Presse Medicale (Paris, France : 1983)|December 23, 2004
[The use of fluoroquinolone plasma levels by physicians]C Pulcini, E Bernard, R Garraffo, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|November 1, 1989
Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reportsR Garraffo, E Cassuto-Viguier, J Barillon, et al.
Lancet (London, England)|July 29, 1989
Fetoplacental passage of zidovudineJ Y Gillet, R Garraffo, D Abrar, et al.
Investigative Ophthalmology & Visual Science|March 1, 1994
Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovirP Berthe, C Baudouin, R Garraffo, et al.
Pathologie-Biologie|April 1, 1991
[Determination of elimination of pefloxacin and of its derivatives in continuous hemodiafiltration]D Journois, D Chanu, J M Ruat, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
Changes in lymphocyte beta-adrenoceptor density after dilevalol oral treatmentV Sbirrazzuoli, M Drici, R Garraffo, et al.
Pageof 7